JP2023516957A5 - - Google Patents
Info
- Publication number
- JP2023516957A5 JP2023516957A5 JP2022551653A JP2022551653A JP2023516957A5 JP 2023516957 A5 JP2023516957 A5 JP 2023516957A5 JP 2022551653 A JP2022551653 A JP 2022551653A JP 2022551653 A JP2022551653 A JP 2022551653A JP 2023516957 A5 JP2023516957 A5 JP 2023516957A5
- Authority
- JP
- Japan
- Prior art keywords
- daptomycin
- excipient
- solid
- reconstitution time
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025120933A JP2025142200A (ja) | 2020-02-28 | 2025-07-18 | ダプトマイシン製剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062982945P | 2020-02-28 | 2020-02-28 | |
| US62/982,945 | 2020-02-28 | ||
| PCT/EP2021/054841 WO2021170807A1 (en) | 2020-02-28 | 2021-02-26 | Daptomycin formulation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025120933A Division JP2025142200A (ja) | 2020-02-28 | 2025-07-18 | ダプトマイシン製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023516957A JP2023516957A (ja) | 2023-04-21 |
| JP2023516957A5 true JP2023516957A5 (enExample) | 2023-12-07 |
Family
ID=74797935
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022551653A Pending JP2023516957A (ja) | 2020-02-28 | 2021-02-26 | ダプトマイシン製剤 |
| JP2025120933A Pending JP2025142200A (ja) | 2020-02-28 | 2025-07-18 | ダプトマイシン製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025120933A Pending JP2025142200A (ja) | 2020-02-28 | 2025-07-18 | ダプトマイシン製剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230068866A1 (enExample) |
| EP (1) | EP4110303A1 (enExample) |
| JP (2) | JP2023516957A (enExample) |
| CN (2) | CN118873500A (enExample) |
| AU (1) | AU2021227095B2 (enExample) |
| BR (1) | BR112022015571A2 (enExample) |
| CA (1) | CA3168727A1 (enExample) |
| MX (1) | MX2022010378A (enExample) |
| WO (1) | WO2021170807A1 (enExample) |
| ZA (1) | ZA202208343B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2770366C2 (ru) | 2017-08-31 | 2022-04-15 | Кселлия Фармасьютикалз Апс | Препараты даптомицина |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003055256A (ja) * | 2001-08-10 | 2003-02-26 | Nihon Pharmaceutical Co Ltd | 安定な血液凝固第ｘｉｉｉ因子製剤 |
| RU2607526C2 (ru) | 2009-11-23 | 2017-01-10 | Кьюбист Фармасьютикалз ЭлЭлСи | Липопептидные композиции и родственные способы |
| RU2770366C2 (ru) * | 2017-08-31 | 2022-04-15 | Кселлия Фармасьютикалз Апс | Препараты даптомицина |
| GB201718888D0 (en) * | 2017-11-15 | 2017-12-27 | Ucb Biopharma Sprl | Method |
-
2021
- 2021-02-26 EP EP21708627.1A patent/EP4110303A1/en active Pending
- 2021-02-26 BR BR112022015571A patent/BR112022015571A2/pt unknown
- 2021-02-26 AU AU2021227095A patent/AU2021227095B2/en active Active
- 2021-02-26 US US17/794,734 patent/US20230068866A1/en active Pending
- 2021-02-26 CA CA3168727A patent/CA3168727A1/en active Pending
- 2021-02-26 CN CN202410944805.5A patent/CN118873500A/zh active Pending
- 2021-02-26 CN CN202180011662.7A patent/CN115038431B/zh active Active
- 2021-02-26 JP JP2022551653A patent/JP2023516957A/ja active Pending
- 2021-02-26 WO PCT/EP2021/054841 patent/WO2021170807A1/en not_active Ceased
- 2021-02-26 MX MX2022010378A patent/MX2022010378A/es unknown
-
2022
- 2022-07-26 ZA ZA2022/08343A patent/ZA202208343B/en unknown
-
2025
- 2025-07-18 JP JP2025120933A patent/JP2025142200A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4612923B2 (ja) | 安定化された４−アミノ−３−置換−ブタン酸誘導体含有製剤およびその製造法 | |
| CN102202688B (zh) | 稳定、干燥的轮状病毒疫苗、其组合物和制备其的方法 | |
| RU2678839C2 (ru) | Композиции для непрерывного введения ингибиторов допа-декарбоксилазы | |
| JP2021521159A5 (enExample) | ||
| JP2020530845A5 (enExample) | ||
| WO2012043696A1 (ja) | ６－フルオロ－３－ヒドロキシ－２－ピラジンカルボキサミドのメグルミン塩 | |
| WO2012043700A1 (ja) | ６－フルオロ－３－ヒドロキシ－２－ピラジンカルボキサミドのナトリウム塩 | |
| WO2020001203A1 (zh) | 一种复方氨基酸维生素注射液及其应用 | |
| US20170189528A1 (en) | Stable aqueous adalimumab formulation | |
| JP2006137678A (ja) | インターロイキン−２組成物 | |
| WO2014142102A1 (ja) | 液体水性組成物 | |
| CN113811290A (zh) | 达托霉素水性制剂 | |
| JP2023516957A5 (enExample) | ||
| TW201538155A (zh) | 活性成份輔助組成物及將活性成份化合物遞送給對象之方法 | |
| TW202017588A (zh) | Hgf冷凍乾燥製劑 | |
| IL311344A (en) | Preparations and methods for the treatment of synoclinopathies | |
| JP2024520526A5 (enExample) | ||
| JP2024534947A5 (enExample) | ||
| WO2018003946A1 (ja) | 凍結乾燥製剤の製造方法 | |
| WO2005066333A1 (en) | Stabilizing compositions for recombinant viruses | |
| JP2025142200A (ja) | ダプトマイシン製剤 | |
| RU2016121401A (ru) | Устойчивые при хранении лиофилизованные составы трипептидов | |
| JP2010540448A5 (enExample) | ||
| JP2025533238A (ja) | 液体ダルババンシン組成物 | |
| RU2018113706A (ru) | Стабильные высококонцентрированные водные композиции ранибизумаба с пролонгированным действием при интравитреальном введении для медицинского применения |